These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18150733)

  • 1. Observations on the development of tolerance during prolonged oral administration of dihydroergocornine.
    MOISTER FC; STANTON JR; FREIS ED
    J Pharmacol Exp Ther; 1949 May; 96(1):21-30. PubMed ID: 18150733
    [No Abstract]   [Full Text] [Related]  

  • 2. The adrenolytic action of dihydroergocornine in man.
    GOETZ RH; KATZ A
    Lancet; 1949 Apr; 1(6553):560-3. PubMed ID: 18124652
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of ergot derivatives on the circulation in man with special reference to two new hydrogenated compounds, dihydroergotamine and dihydroergocornine.
    BLUNTSCHILI JH; GOETZ RH
    Am Heart J; 1948 Jun; 35(6):873-94. PubMed ID: 18863738
    [No Abstract]   [Full Text] [Related]  

  • 4. The hemodynamic effects of hypotensive drugs in man; dihydroergocornine.
    FREIS ED; STANTON JR
    J Clin Invest; 1949 Nov; 28(6 Pt 2):1387-1402. PubMed ID: 15395942
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac effects of dihydroergocornine.
    LEIK DW; ELEK SR
    Am J Med; 1950 Apr; 8(4):539. PubMed ID: 15410769
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of dihydroergocornine on the peripheral circulation in man.
    HAYES DW; WAKIM KG
    J Lab Clin Med; 1948 Nov; 33(11):1497. PubMed ID: 18890081
    [No Abstract]   [Full Text] [Related]  

  • 7. The renal hemodynamic effects of dihydroergocornine (DHO-180) in man.
    CROSLEY AP; CUMMINS AJ; BARKER HG; CLARK JK
    J Pharmacol Exp Ther; 1950 Feb; 98(2):138-43. PubMed ID: 15422506
    [No Abstract]   [Full Text] [Related]  

  • 8. The action of dihydroergocornine on the circulation with special reference to hypertension.
    GOETZ RH
    Lancet; 1949 Mar; 1(6552):510-4. PubMed ID: 18114005
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of intramuscular dihydroergocornine on the cerebral circulation in normotensive patients.
    HAFKENSCHIEL JH; CRUMPTON CW; MOYER JH
    J Pharmacol Exp Ther; 1950 Feb; 98(2):144-6. PubMed ID: 15422507
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of the effect of dihydroergocornine on the blood pressure in differential diagnosis of hypertension].
    EISELT E; POKORNY J
    Cas Lek Cesk; 1949 Aug; 88(31):890-3. PubMed ID: 18140609
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of orally administered dihydroergocornine (D.H.O. 180) on hypertension.
    BELLO CT; MOSS WG; WEISS E
    Am J Med; 1950 May; 8(5):634-9. PubMed ID: 15413629
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydroergocornine in the differential diagnosis of functional heart disturbances and organic heart disease.
    PORDY L; ARAI HS; MASTER AM
    J Mt Sinai Hosp N Y; 1950; 17(1):26-37. PubMed ID: 15422353
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of dihydroergocornine on the cerebral circulation of patients with essential hypertension.
    HAFKENSCHIEL JH; CRUMPTON CW; MOYER JH; JEFFERS WA; FISHEL HANLEY B; CONLIN HARNED S
    J Clin Invest; 1950 Apr; 29(4):408-11. PubMed ID: 15415441
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of dihydroergocornine on the pulmonary response to methacholine and histamine in subjects with bronchial asthma.
    CURRY JJ; FUCHS JE; LEARD SE
    J Clin Invest; 1950 Apr; 29(4):439-43. PubMed ID: 15415444
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of dihydroergotamine and dihydroergocornine on cardiac output and blood pressure in hypertension.
    WERKO L; LAGERLOF H
    Cardiologia (Basel); 1949; 15(2):120-6. PubMed ID: 15394425
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of pyrogen-induced renal hyperemia in the dog by dihydroergocornine.
    TAKOS MJ; MOE GK
    Proc Soc Exp Biol Med; 1950 Oct; 75(1):51-2. PubMed ID: 14797732
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of dihydroergocornine on the cardiovascular system in man; blood pressure, heart rate, and resting electrocardiogram.
    ARAI HS; PORDY L; MASTER AM
    J Mt Sinai Hosp N Y; 1951; 18(2):119-24. PubMed ID: 14861634
    [No Abstract]   [Full Text] [Related]  

  • 18. Objective evaluation of physical and drug therapy in the rehabilitation of the hemiplegic patient. I. A study of dihydroergocornine (DHO-180).
    BENTON JG; BROWN H; RINZLER SH
    Am Heart J; 1951 Nov; 42(5):719-32. PubMed ID: 14885068
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dihydroergocornine and its action].
    POKORNY J
    Cas Lek Cesk; 1949 Oct; 88(42):1218-20. PubMed ID: 15391411
    [No Abstract]   [Full Text] [Related]  

  • 20. The prophylactic use of combined hydrogenated ergot alkaloids, dihydroergocornine, dihydroergocristine and dihydroergokryptine in migraine.
    BERCEL NA
    Am Pract Dig Treat; 1955 Mar; 6(3):348-52. PubMed ID: 14350151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.